Automate Your Wheel Strategy on EHAB
With Tiblio's Option Bot, you can configure your own wheel strategy including EHAB - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol EHAB
- Rev/Share 20.4416
- Book/Share 0.301
- PB 34.8849
- Debt/Equity 0.0066
- CurrentRatio 2.6667
- ROIC -7.4635
- MktCap 531692879.0
- FreeCF/Share 0.9802
- PFCF 10.7413
- PE -3.8258
- Debt/Assets 0.0061
- DivYield 0
- ROE -0.3116
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 4
- P/B Score 1
- D/E Score 4
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | EHAB | Jefferies | Hold | Buy | $8.25 | $9.5 | Dec. 9, 2024 |
News
Enhabit, Inc. (EHAB) Q1 2025 Earnings Call Transcript
Published: May 11, 2025 by: Seeking Alpha
Sentiment: Neutral
Start Time: 10:00 January 1, 0000 10:27 AM ET Enhabit, Inc. (NYSE:EHAB ) Q1 2025 Earnings Conference Call May 08, 2025, 10:00 AM ET Company Participants Barb Jacobsmeyer - President and CEO Ryan Solomon - CFO Jobie Williams - SVP and Treasurer Conference Call Participants Brian Tanquilut - Jefferies AJ Rice - UBS Ryan Langston - TD Cowen Whit Mayo - Leerink Partners Operator Hello. Good morning, everyone, and welcome to Enhabit Home Health & Hospice's First Quarter 2025 Earnings Conference Call.
Read More
Enhabit (EHAB) Q1 Earnings Top Estimates
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Enhabit (EHAB) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to earnings of $0.07 per share a year ago.
Read More
Is Enhabit, Inc. (EHAB) Stock Outpacing Its Medical Peers This Year?
Published: April 10, 2025 by: Zacks Investment Research
Sentiment: Positive
Here is how Enhabit (EHAB) and Doximity (DOCS) have performed compared to their sector so far this year.
Read More
Why Fast-paced Mover Enhabit (EHAB) Is a Great Choice for Value Investors
Published: March 26, 2025 by: Zacks Investment Research
Sentiment: Positive
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Enhabit (EHAB) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Read More
Surging Earnings Estimates Signal Upside for Enhabit (EHAB) Stock
Published: March 19, 2025 by: Zacks Investment Research
Sentiment: Positive
Enhabit (EHAB) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Read More
Enhabit (EHAB) Is Attractively Priced Despite Fast-paced Momentum
Published: February 21, 2025 by: Zacks Investment Research
Sentiment: Positive
Enhabit (EHAB) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Read More
About Enhabit, Inc. (EHAB)
- IPO Date 2022-06-23
- Website https://www.ehab.com
- Industry Medical - Care Facilities
- CEO Ms. Barbara Ann Jacobsmeyer B.S., M.A., P.T.
- Employees 10600